Free Access
Supplement Table 2
| function | SL_PSC | F_PSC | distance |
|---|---|---|---|
| hsa04514:Cell adhesion molecules (CAMs) | -1.02 | -0.3 | 0.72 |
| GO:0051251~positive regulation of lymphocyte activation | -1.14 | -0.3 | 0.84 |
| GO:0070665~positive regulation of leukocyte proliferation | -0.95 | -0.2 | 0.75 |
| GO:0051173~positive regulation of nitrogen compound metabolic process | -0.85 | -0.76 | 0.09 |
| GO:0050870~positive regulation of T cell activation | -1.11 | -0.28 | 0.83 |
| GO:0045941~positive regulation of transcription | -0.83 | -0.74 | 0.09 |
| GO:0010468~regulation of gene expression | -1.16 | -1.07 | 0.09 |
| GO:0045893~positive regulation of transcription, DNA-dependent | -0.79 | -0.71 | 0.08 |
| GO:0008285~negative regulation of cell proliferation | -0.82 | -0.64 | 0.18 |
| GO:0044257~cellular protein catabolic process | -0.88 | -0.77 | 0.11 |
| GO:0016568~chromatin modification | -0.76 | -0.67 | 0.09 |
| GO:0043067~regulation of programmed cell death | -1.18 | -0.45 | 0.73 |
| GO:0030098~lymphocyte differentiation | -1.11 | -0.26 | 0.85 |
| hsa04662:B cell receptor signaling pathway | -1.09 | -0.31 | 0.78 |
| GO:0042981~regulation of apoptosis | -1.18 | -0.45 | 0.73 |
| GO:0070663~regulation of leukocyte proliferation | -1.08 | -0.27 | 0.81 |
| GO:0030163~protein catabolic process | -0.89 | -0.78 | 0.11 |
| GO:0032944~regulation of mononuclear cell proliferation | -1.08 | -0.27 | 0.81 |
| GO:0042110~T cell activation | -1.02 | -0.37 | 0.65 |
| GO:0019221~cytokine-mediated signaling pathway | -0.88 | -0.31 | 0.57 |
| GO:0050857~positive regulation of antigen receptor-mediated signaling pathway | -1.14 | -0.13 | 1.01 |
| hsa04940:Type I diabetes mellitus | -1.01 | -0.21 | 0.8 |
| GO:0050671~positive regulation of lymphocyte proliferation | -0.95 | -0.2 | 0.75 |
| GO:0010557~positive regulation of macromolecule biosynthetic process | -0.86 | -0.76 | 0.1 |
| GO:0050867~positive regulation of cell activation | -1.16 | -0.32 | 0.84 |
| GO:0016071~mRNA metabolic process | -0.8 | -0.64 | 0.16 |
| GO:0051249~regulation of lymphocyte activation | -1.25 | -0.38 | 0.87 |
| GO:0043388~positive regulation of DNA binding | -0.84 | -0.25 | 0.59 |
| GO:0032946~positive regulation of mononuclear cell proliferation | -0.95 | -0.2 | 0.75 |
| GO:0045577~regulation of B cell differentiation | -0.88 | -0.14 | 0.74 |
| GO:0006355~regulation of transcription, DNA-dependent | -1.04 | -0.95 | 0.09 |
| GO:0002696~positive regulation of leukocyte activation | -1.16 | -0.32 | 0.84 |
| GO:0030101~natural killer cell activation | -0.96 | -0.21 | 0.75 |
| GO:0051254~positive regulation of RNA metabolic process | -0.79 | -0.71 | 0.08 |
| hsa05340:Primary immunodeficiency | -1.2 | -0.2 | 1 |
| GO:0016070~RNA metabolic process | -0.98 | -0.84 | 0.14 |
| GO:0007166~cell surface receptor linked signal transduction | -1.31 | -0.62 | 0.69 |
| GO:0040029~regulation of gene expression, epigenetic | -0.5 | -0.45 | 0.05 |
| GO:0031326~regulation of cellular biosynthetic process | -1.16 | -1.06 | 0.1 |
| hsa05330:Allograft rejection | -1.01 | -0.21 | 0.8 |
| hsa04660:T cell receptor signaling pathway | -1.19 | -0.29 | 0.9 |
| GO:0019219~regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | -1.14 | -1.05 | 0.09 |
| GO:0015031~protein transport | -0.98 | -0.8 | 0.18 |
| GO:0045449~regulation of transcription | -1.13 | -1.04 | 0.09 |
| hsa04650:Natural killer cell mediated cytotoxicity | -1.1 | -0.28 | 0.82 |
| GO:0050778~positive regulation of immune response | -1.12 | -0.29 | 0.83 |
| GO:0050854~regulation of antigen receptor-mediated signaling pathway | -1.14 | -0.13 | 1.01 |
| GO:0050670~regulation of lymphocyte proliferation | -1.08 | -0.27 | 0.81 |
| GO:0050863~regulation of T cell activation | -1.14 | -0.3 | 0.84 |
| GO:0002694~regulation of leukocyte activation | -1.25 | -0.38 | 0.87 |
| GO:0051252~regulation of RNA metabolic process | -1.04 | -0.95 | 0.09 |
| GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | -0.85 | -0.75 | 0.1 |
| GO:0010628~positive regulation of gene expression | -0.83 | -0.74 | 0.09 |
| GO:0002521~leukocyte differentiation | -1.11 | -0.31 | 0.8 |
| GO:0043632~modification-dependent macromolecule catabolic process | -0.88 | -0.77 | 0.11 |
| GO:0006396~RNA processing | -0.88 | -0.72 | 0.16 |
| GO:0044267~cellular protein metabolic process | -1.14 | -1.01 | 0.13 |
| GO:0006464~protein modification process | -1.05 | -0.91 | 0.14 |
| GO:0050871~positive regulation of B cell activation | -0.93 | -0.21 | 0.72 |
| GO:0010556~regulation of macromolecule biosynthetic process | -1.15 | -1.06 | 0.09 |
| GO:0045619~regulation of lymphocyte differentiation | -1.01 | -0.25 | 0.76 |
| hsa04060:Cytokine-cytokine receptor interaction | -1.29 | -0.43 | 0.86 |
| GO:0050864~regulation of B cell activation | -1.1 | -0.29 | 0.81 |
| hsa05332:Graft-versus-host disease | -1.01 | -0.21 | 0.8 |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.